Clinical Trial Update: Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior Uveitis [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and efficacy of a FAI insert for chronic non-infectious posterior uveitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermediate Uveitis
• Panuveitis
• Posterior Uveitis

Drugs mentioned

• FAI insert

Snippet

Sponsor: EyePoint Pharmaceuticals, Inc. | Conditions: Posterior Uveitis, Intermediate Uveitis | Phase 3 | Status: COMPLETED | Results posted: 2020-07-07